Radiolabeling lipoproteins to study and manage disease

Area of Science:

• Nanomedicine
• Biochemistry
• Nuclear Medicine

Background:

• Lipoproteins are endogenous nanoparticles vital for lipid transport and inflammation.
• Lipoprotein abnormalities are implicated in diseases like atherosclerosis.
• Radiolabeling offers a powerful method for studying and utilizing lipoproteins.

Purpose of the Study:

• To review radiochemistry and nuclear imaging applications in studying lipoproteins.
• To detail radiolabeling approaches for lipoproteins.
• To highlight advancements in understanding lipoprotein biology and disease management.

Main Methods:

• Extensive literature search of peer-reviewed studies on radiolabeled lipoproteins.
• Selection of representative examples for key discoveries and technological advancements.

Main Results:

• Over 200 studies utilize radiolabeled lipoproteins.
• Applications span mechanistic, diagnostic, and therapeutic research.
• Significant contributions to understanding atherosclerosis, cancer, and hypercholesteremia.

Conclusions:

• Radiolabeling is essential for advancing lipoprotein biology.
• Radiolabeled lipoproteins are key for disease diagnosis and treatment.
• This approach leverages lipoproteins as nanomaterials for medical applications.